Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Intraocular lens implants

A 0.1% ophthalmic preparation is recommended for prevention of postoperative ophthalmic inflammation and can be used after intraocular lens implantation and strabismus surgery. A topical gel containing 3% diclofenac is effective for solar keratoses. Diclofenac in rectal suppository form can be considered for preemptive analgesia and postoperative nausea. In Europe, diclofenac is also available as an oral mouthwash and for intramuscular administration. [Pg.803]

Tetracaine, an ester of para-aminobenzoic acid (PABA), has been widely used for topical anesthesia of the eye. It is currently available in a 0.5% solution. Its onset, intensity, and duration of anesthesia are comparable with those of proparacaine and benoxinate (Figure 6-2). Onset of anesthesia sufficient to permit tonometry or other minor procedures involving the superficial cornea and conjimc-tiva is 10 to 20 seconds, and duration of anesthesia is 10 to 20 minutes. It has been reported, however, that the 1% solution produces anesthesia lasting nearly an hour. Tetracaine 1% has also been used successfully to provide anesthesia during phacoemulsification cataract surgery and intraocular lens implantation. [Pg.88]

Ponte F, C.illino S, Faranda F, et al. Intraocular dapiprazole for the reversal of mydriasis after cataract extraction with intraocular lens implantation. J Cataract Refract Surg 1991 17 785-789. [Pg.123]

Hyaluronic acid is considered to have low inflammatory and antigenic potential, and has been used in various intraocular procedures. In addition to filtration bleb formation, it has been used to protect the corneal endothelium during intraocular lens implantation and keratoplasty, to reform the anterior chamber, to push back a bulging vitreous face, and in retinal detachment surgery as a vitreous replacement. [Pg.1699]

A subsequent Phase II, multicenter, randomized, double-masked, placebo-controlled clinical trial was performed in patients undergoing phacoemulsification and intraocular lens implantation (18). Only one eye per patient was eligible for treatment and exclusion criteria included previous uveitis, concurrent anterior segment disease or intraoperative surgical complications. Patients were randomized in a 2 1 ratio into an active treatment group or a control group. Patients in the two... [Pg.268]

Saika et al. (79) reported on a group of 19 eyes that had pars plana vitrectomy, elevation of the posterior hyaloid, fluid gas exchange, and cataract extraction with intraocular lens implant. Ten of the 19 eyes had decreased in macular edema as identified on optical coherence tomography the mean thickness decreased from 383 to 208 pm. However, there was no statistically significant improvement in visual acuity. If only patients with more recent onset of branch retinal vein occlusion were included in the analysis, a visual improvement was noted. [Pg.318]

The lens of the eye sometimes becomes opaque (cataract formation), apparently due to cross-linking of its proteinaceous material, and must be removed to restore vision. Intraocular lens implants are normally made from poly(methyl methacrylate), although other materials. Including hydrogels, have been tried. In over 73% of the cases, vision of 20/40 or better can be achieved by these implants (67). The cornea is also subject to cataract formation and... [Pg.549]

Topical heparin eyedrops were effective for long-term reduction of fibrotic posterior capsule opacification after extracapsular cataract extraction with intraocular lens implantation (93). Implantation of a heparin drug delivery system into the posterior chamber of experimental animals maintained a significantly higher heparin level in the aqueous humor for a long period of time, suggesting the potential for effective prevention of posterior capsular opacification after phacoemulsification of the lens with no toxic or side effects (94). [Pg.195]

Ravalico G, Tognetto D, Baccara F. Heparin-surface-modified intraocular lens implantation in eyes with pseudoexfoliation syndrome. J Cataract Refract Surg 1994 20 543-549. [Pg.205]

Balazs EA, Miller D, Stegmann R. Viscosurgery and the use of Na-hyaluro-nate in intraocular lens implantation. In International Congress and First Film Festival on Intraocular Implantation, Cannes, France, 1979 l-6. [Pg.326]

Shirley, H.L. Chang, M.D. Gerald Lim, M.D. Secondary pigmentary glaucoma associated with piggyback intraocular lens implantation. Case report. J. Cataract Refract. Surg. 2004,30 (10), 2219-2222. [Pg.1219]

D.P. DeVore, Long-tmn compatibihty of intraocular lens implant materials, J. Long Term Eff. Med. Implants 1 (1991) 205-216. [Pg.326]

Following the polishing of the capsule, viscoelastic is injected to unfold and extend the capsular bag (Fig. 68) thereby occupying space to facilitate intraocular lens implantation. [Pg.68]

Alpar JJ, Alpar AJ, Baca J, Chapman D. Comparison of Healon and Viscoat in cataract extraction and intraocular lens implantation. Ophthalmic Surg 1988 19 636-642... [Pg.133]

Aron-Rosa D, Cohn HC, Aron J-J, Boquety C. Methylcellulose instead of Healon in extracapsular surgery with intraocular lens implantation. Ophthalmology 1983 90 1235-1238... [Pg.133]

Darzynkiewisz Z, Balazs EA. Effect of connective tissue intercellular matrix on lymphocyte stimulation. I. Suppression of lymphocyte stimulation by hyaluronic acid. Exp Cell Res 1971 66 113-123 Davison JA. Capsular bag distension after endophacoemulsification and posterior chamber intraocular lens implantation. J Cataract Refract Surg 190 16 99-108 DeLuise VP, Peterson WJ. The use of topical Healon tears in the management of refractory dry-eye syndrome. Ann Ophthalmol 1984 16 823-824... [Pg.136]

Liesegang TJ, Bourne WM, Ilstrup DM. The use of hydroxypropyl methylcellulose in extracapsular cataract extraction with intraocular lens implantation. Am J Ophthalmol 1986 102 723-726 Liesegang TJ. Viscoelastic substances in ophthalmology. Surv Ophthalmol 1990 34 268-293... [Pg.140]

Madsen K, Schenholm M, Jahnke G, Tengblad A. Hyaluronate binding to intact corneas and cultured endothelial cells. Invest Ophthalmol Vis Sci 1989b 30 2132-2137 Maguen E, Nesburn AB, Macy JI. Combined use of sodium hyaluronate and tissue adhesive in penetrating keratoplasty of corneal perforations. Ophthalmic Surg 1984 15 55-57 Mandelcorn M. Viscoelastic dissection for relocation of off-axis intraocular lens implant a new technique. Can J Ophthalmol 1995 30 34-35... [Pg.141]

Miller D, O Connor P, Williams J. Use of Na-hyaluronate during intraocular lens implantation in rabbits. Ophthalmic Surg 1977 8 58-61... [Pg.141]

Savage JA, Thomas JV, Belcher CD III, Simmons RJ. Extracapsular cataract extraction and posterior chamber intraocular lens implantation in glaucomatous eyes. Ophthalmology 1985 92 1506-1516 Scheie HG. Filtration operations for glaucoma A comparative study. Am J Ophthalmol 1962 53 571-590... [Pg.143]

Patel AS. Intraocular lens implants a scientific perspective. In Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials science an introduction to materials in medicine. San Diego, CA Elsevier 2004. [chapter 7.11],... [Pg.158]

San Francisco, Ca., Spring 1997, p. 128-9. 012 ATOMIC FORCE MICROSCOPY STUDY OF INTRAOCULAR LENS IMPLANTS -TOPOGRAPHY AND SURFACE PROPERTIES Kowalewski T Ravi V N Washington,University St.Louis,Veterans Affairs Medical Center... [Pg.95]

See other pages where Intraocular lens implants is mentioned: [Pg.47]    [Pg.125]    [Pg.229]    [Pg.493]    [Pg.139]    [Pg.139]    [Pg.318]    [Pg.27]    [Pg.312]    [Pg.314]    [Pg.308]    [Pg.135]    [Pg.138]    [Pg.1368]    [Pg.213]    [Pg.155]    [Pg.190]    [Pg.73]   
See also in sourсe #XX -- [ Pg.44 ]

See also in sourсe #XX -- [ Pg.310 ]



SEARCH



Implantation, intraocular

Intraocular

Intraocular implants

Intraocular lenses

© 2024 chempedia.info